Beijing Strong Biotechnologies Inc Total Liabilities
Beijing Strong Biotechnologies Inc total liabilities. Based on the latest financial reports, Beijing Strong Biotechnologies Inc (300406) has total liabilities worth CN¥1.30 Billion CNY (≈ $190.20 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 300406 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Beijing Strong Biotechnologies Inc (2011–2024)
Total liabilities of Beijing Strong Biotechnologies Inc from 2011 to 2024. This chart illustrates how Beijing Strong Biotechnologies Inc's total liabilities have evolved over time, based on quarterly financial data. Explore Beijing Strong Biotechnologies Inc (300406) long-term investment share to see how much of total assets are deployed in long-term investments.
Beijing Strong Biotechnologies Inc Competitors by Total Liabilities
The table below lists competitors of Beijing Strong Biotechnologies Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Meitav Dash Investments Ltd
TA:MTDS
|
Israel | ILA3.61 Billion |
|
Longwell Co
TWO:6290
|
Taiwan | NT$5.45 Billion |
|
Tips Music Limited
NSE:TIPSMUSIC
|
India | Rs1.02 Billion |
|
Shenzhen United Winners Laser Co Ltd
SHG:688518
|
China | CN¥4.62 Billion |
|
Beijing Urban Rural Commercial Group Co Ltd
SHG:600861
|
China | CN¥7.88 Billion |
|
Hartalega Holdings Bhd
KLSE:5168
|
Malaysia | RM495.00 Million |
|
Guangzhou Hexin Instrument Co Ltd
SHG:688622
|
China | CN¥464.96 Million |
|
Innovative Medical Management Co Ltd
SHE:002173
|
China | CN¥387.09 Million |
Liability Composition Analysis (2011–2024)
This chart breaks down Beijing Strong Biotechnologies Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 300406 total assets.
Liquidity & Leverage Metrics
Beijing Strong Biotechnologies Inc Total Liabilities Ratios Explained
Beijing Strong Biotechnologies Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 11.66 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.32 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.25 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Beijing Strong Biotechnologies Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Beijing Strong Biotechnologies Inc (2011–2024)
The table below shows the annual total liabilities of Beijing Strong Biotechnologies Inc from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥1.44 Billion ≈ $211.03 Million |
-0.83% |
| 2023-12-31 | CN¥1.45 Billion ≈ $212.79 Million |
+8.19% |
| 2022-12-31 | CN¥1.34 Billion ≈ $196.69 Million |
-4.43% |
| 2021-12-31 | CN¥1.41 Billion ≈ $205.79 Million |
+160.34% |
| 2020-12-31 | CN¥540.20 Million ≈ $79.05 Million |
+195.05% |
| 2019-12-31 | CN¥183.09 Million ≈ $26.79 Million |
+12.65% |
| 2018-12-31 | CN¥162.52 Million ≈ $23.78 Million |
-34.64% |
| 2017-12-31 | CN¥248.65 Million ≈ $36.39 Million |
+199.26% |
| 2016-12-31 | CN¥83.09 Million ≈ $12.16 Million |
-4.01% |
| 2015-12-31 | CN¥86.56 Million ≈ $12.67 Million |
+50.68% |
| 2014-12-31 | CN¥57.44 Million ≈ $8.41 Million |
+28.88% |
| 2013-12-31 | CN¥44.57 Million ≈ $6.52 Million |
-4.78% |
| 2012-12-31 | CN¥46.81 Million ≈ $6.85 Million |
+66.97% |
| 2011-12-31 | CN¥28.04 Million ≈ $4.10 Million |
-- |
About Beijing Strong Biotechnologies Inc
Beijing Strong Biotechnologies,Inc. researches, develops, manufactures, and sells in-vitro diagnostics (IVD) products and services in China and internationally. The company offers biochemistry reagents, including liver, renal, lipid, cardiac, diabetes, special protein, tumor marker, pancreas, inorganic, inflammation, TDM, and other panels; and coagulation products, such as prothrombin time, activ… Read more